Sphingoid Bases Regulate the Sigma-1 Receptor—Sphingosine and N,N’-Dimethylsphingosine Are Endogenous Agonists

Both bioactive sphingolipids and Sigma-1 receptor (S1R) chaperones occur ubiquitously in mammalian cell membranes. Endogenous compounds that regulate the S1R are important for controlling S1R responses to cellular stress. Herein, we interrogated the S1R in intact Retinal Pigment Epithelial cells (ARPE-19) with the bioactive sphingoid base, sphingosine (SPH), or the pain-provoking dimethylated SPH derivative, N,N’-dimethylsphingosine (DMS). As informed by a modified native gel approach, the basal and antagonist (BD-1047)-stabilized S1R oligomers dissociated to protomeric forms in the presence of SPH or DMS (PRE-084 as control). We, thus, posited that SPH and DMS are endogenous S1R agonists. Consistently, in silico docking of SPH and DMS to the S1R protomer showed strong associations with Asp126 and Glu172 in the cupin beta barrel and extensive van der Waals interactions of the C18 alkyl chains with the binding site including residues in helices 4 and 5. Mean docking free energies were 8.73–8.93 kcal/mol for SPH and 8.56–8.15 kcal/mol for DMS, and calculated binding constants were ~40 nM for SPH and ~120 nM for DMS. We hypothesize that SPH, DMS, and similar sphingoid bases access the S1R beta barrel via a membrane bilayer pathway. We further propose that the enzymatic control of ceramide concentrations in intracellular membranes as the primary sources of SPH dictates availability of endogenous SPH and DMS to the S1R and the subsequent control of S1R activity within the same cell and/or in cellular environments.

[1]  Hongji Sun,et al.  The regulatory role of endoplasmic reticulum chaperone proteins in neurodevelopment , 2022, Frontiers in Neuroscience.

[2]  F. López-Muñoz,et al.  The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents. , 2022, ACS pharmacology & translational science.

[3]  L. Baer,et al.  Differential Responses to Sigma-1 or Sigma-2 Receptor Ablation in Adiposity, Fat Oxidation, and Sexual Dimorphism , 2022, International journal of molecular sciences.

[4]  M. Geva,et al.  Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine , 2022, Autophagy.

[5]  D. Zamanillo,et al.  Comprehensive Preclinical Assessment of Sensory, Functional, Motivational-Affective, and Neurochemical Outcomes in Neuropathic Pain: The Case of the Sigma-1 Receptor. , 2022, ACS pharmacology & translational science.

[6]  Ziyi Sun,et al.  An open-like conformation of the sigma-1 receptor reveals its ligand entry pathway , 2022, Nature Communications.

[7]  H. Oki,et al.  Discovery of Brain-Penetrant Glucosylceramide Synthase Inhibitors with a Novel Pharmacophore. , 2022, Journal of medicinal chemistry.

[8]  Steven B. Bradfute,et al.  Mammalian hybrid pre-autophagosomal structure HyPAS generates autophagosomes , 2021, Cell.

[9]  R. Mallik,et al.  Mapping Sphingolipid Metabolism Pathways during Phagosomal Maturation. , 2021, ACS chemical biology.

[10]  N. Ben-Tal,et al.  The Sigma-1 receptor is an ER-localized type II membrane protein , 2021, The Journal of biological chemistry.

[11]  M. Bhuiyan,et al.  Sigmar1’s Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology , 2021, Frontiers in Physiology.

[12]  M. Leopoldo,et al.  Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives , 2021, International journal of molecular sciences.

[13]  L. Salerno,et al.  Development of New Benzylpiperazine Derivatives as σ1 Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects , 2021, ACS chemical neuroscience.

[14]  M. Hayden,et al.  Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases , 2021, International journal of molecular sciences.

[15]  T. Su,et al.  Genomic Action of Sigma-1 Receptor Chaperone Relates to Neuropathic Pain , 2021, Molecular Neurobiology.

[16]  A. Pertovaara,et al.  Spinal mechanisms contributing to the development of pain hypersensitivity induced by sphingolipids in the rat , 2021, Pharmacological Reports.

[17]  I. Bezprozvanny,et al.  The role of sigma-1 receptor in organization of endoplasmic reticulum signaling microdomains , 2020, bioRxiv.

[18]  Na Ye,et al.  Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. , 2020, Journal of medicinal chemistry.

[19]  T. Maurice Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders , 2020, Expert opinion on drug discovery.

[20]  Yolima P. Torres,et al.  TRP Channels Role in Pain Associated With Neurodegenerative Diseases , 2020, Frontiers in Neuroscience.

[21]  K. Stanford,et al.  Sigma-1 receptor ablation impedes adipocyte-like differentiation of mouse embryonic fibroblasts. , 2020, Cellular signalling.

[22]  Daniel A. Greenfield,et al.  Virtual Screening for Ligand Discovery at the σ1 Receptor. , 2020, ACS medicinal chemistry letters.

[23]  T. Tencomnao,et al.  Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression , 2020, Scientific Reports.

[24]  Giacomo Rossino,et al.  New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative , 2019, J. Chem. Inf. Model..

[25]  D. Schneider,et al.  Lipid Binding Controls Dimerization of the Coat Protein p24 Transmembrane Helix. , 2019, Biophysical journal.

[26]  G. Galdino,et al.  The role of oligodendrocytes in chronic pain: cellular and molecular mechanisms. , 2019, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[27]  I. Bezprozvanny,et al.  Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases , 2019, Front. Neurosci..

[28]  Lei Shi,et al.  The Effects of Terminal Tagging on Homomeric Interactions of the Sigma 1 Receptor , 2019, bioRxiv.

[29]  H. Schmidt,et al.  The Molecular Function of σ Receptors: Past, Present, and Future. , 2019, Trends in pharmacological sciences.

[30]  Teruo Hayashi The Sigma-1 Receptor in Cellular Stress Signaling , 2019, Front. Neurosci..

[31]  W. Hong Distinct regulation of sigma‐1 receptor multimerization by its agonists and antagonists , 2019, The FASEB Journal.

[32]  Lian‐Wang Guo,et al.  SIGMAR1/Sigma-1 receptor ablation impairs autophagosome clearance , 2019, Autophagy.

[33]  R. Klevit,et al.  Mechanisms of Small Heat Shock Proteins. , 2019, Cold Spring Harbor perspectives in biology.

[34]  Colin W. Taylor,et al.  Choline Is an Intracellular Messenger Linking Extracellular Stimuli to IP3-Evoked Ca2+ Signals through Sigma-1 Receptors , 2019, Cell reports.

[35]  Liana C. Silva,et al.  The role of ceramide in regulating endoplasmic reticulum function. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[36]  K. Bollinger,et al.  Sigma 1 receptor: A novel therapeutic target in retinal disease , 2018, Progress in Retinal and Eye Research.

[37]  J. Buchner,et al.  Small heat shock proteins: Simplicity meets complexity , 2018, The Journal of Biological Chemistry.

[38]  P. Brust,et al.  Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety. , 2018, Journal of medicinal chemistry.

[39]  Ara M. Abramyan,et al.  Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays , 2018, Neuropharmacology.

[40]  T. Tencomnao,et al.  Dipentylammonium Binds to the Sigma-1 Receptor and Protects Against Glutamate Toxicity, Attenuates Dopamine Toxicity and Potentiates Neurite Outgrowth in Various Cultured Cell Lines , 2018, Neurotoxicity Research.

[41]  M. Hiriart,et al.  TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain , 2018, Proceedings of the National Academy of Sciences.

[42]  M. B. Bauer,et al.  Sigma‐1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors , 2017, Journal of neurochemistry.

[43]  J. Yang,et al.  APEX2- tagging of Sigma 1-receptor indicates subcellular protein topology with cytosolic N-terminus and ER luminal C-terminus , 2017, Protein & Cell.

[44]  J. Yang,et al.  APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum. , 2017, Oncotarget.

[45]  S. Amara,et al.  The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats , 2017, The Journal of Biological Chemistry.

[46]  E. Bieberich,et al.  Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease , 2016, Journal of neuroscience research.

[47]  S. Pyne,et al.  Sphingosine Kinases: Emerging Structure-Function Insights. , 2016, Trends in biochemical sciences.

[48]  H. Schmidt,et al.  Crystal structure of the human σ1 receptor , 2016, Nature.

[49]  Shang-Yi Tsai,et al.  The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems. , 2016, Trends in pharmacological sciences.

[50]  A. Bonci,et al.  Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope , 2015, Proceedings of the National Academy of Sciences.

[51]  Caroline H. Johnson,et al.  Alterations in Spinal Cord Metabolism during Treatment of Neuropathic Pain , 2015, Journal of Neuroimmune Pharmacology.

[52]  T. Su,et al.  Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid , 2015, Proceedings of the National Academy of Sciences.

[53]  S. Spiegel,et al.  Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. , 2015, Experimental cell research.

[54]  E. Sibille,et al.  Sigma-1 and N-Methyl-D-Aspartate Receptors: A Partnership with Beneficial Outcomes , 2015, Molecular Neuropsychiatry.

[55]  Deo R. Singh,et al.  The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. , 2015, The Biochemical journal.

[56]  G. Patti,et al.  Inflammation triggers production of dimethylsphingosine from oligodendrocytes , 2014, Neuroscience.

[57]  G. von Heijne,et al.  Identification of novel sphingolipid-binding motifs in mammalian membrane proteins. , 2014, Biochimica et biophysica acta.

[58]  C. Arenz,et al.  Small Molecule Inhibitors of Ceramidases , 2014, Cellular Physiology and Biochemistry.

[59]  B. Fox,et al.  The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands , 2014, The Journal of Biological Chemistry.

[60]  B. Brügger,et al.  Sphingolipids as modulators of membrane proteins. , 2014, Biochimica et biophysica acta.

[61]  Nidhi Kaushal,et al.  Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects. , 2014, Advances in pharmacology.

[62]  J. Schnell,et al.  Characterization of the Human Sigma-1 Receptor Chaperone Domain Structure and Binding Immunoglobulin Protein (BiP) Interactions* , 2013, The Journal of Biological Chemistry.

[63]  Jacques Fantini,et al.  How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains , 2013, Front. Physiol..

[64]  M. Kress,et al.  Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain. , 2013, Trends in pharmacological sciences.

[65]  D. Selley,et al.  Sphingosine-1-phosphate receptors as emerging targets for treatment of pain. , 2012, Biochemical pharmacology.

[66]  S. Kourrich,et al.  The sigma-1 receptor: roles in neuronal plasticity and disease , 2012, Trends in Neurosciences.

[67]  Alexander D. MacKerell,et al.  Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing , 2012, J. Chem. Inf. Model..

[68]  Teruo Hayashi,et al.  The Lifetime of UDP-galactose:Ceramide Galactosyltransferase Is Controlled by a Distinct Endoplasmic Reticulum-associated Degradation (ERAD) Regulated by Sigma-1 Receptor Chaperones* , 2012, The Journal of Biological Chemistry.

[69]  A. Hajipour,et al.  The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines. , 2012, Current pharmaceutical design.

[70]  R. Pepperkok,et al.  Molecular recognition of a single sphingolipid species by a protein’s transmembrane domain , 2012, Nature.

[71]  K. Oh-hashi,et al.  Chloroquine inhibits glutamate‐induced death of a neuronal cell line by reducing reactive oxygen species through sigma‐1 receptor , 2011, Journal of neurochemistry.

[72]  A. Hajipour,et al.  Characterization of interactions of 4-nitrophenylpropyl-N-alkylamine with ς receptors. , 2011, Biochemistry.

[73]  S. Safrany,et al.  Antagonists show GTP‐sensitive high‐affinity binding to the sigma‐1 receptor , 2011, British journal of pharmacology.

[74]  L. Obeid,et al.  Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[76]  Tangui Maurice,et al.  The pharmacology of sigma-1 receptors. , 2009, Pharmacology & therapeutics.

[77]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[78]  S. Pyne,et al.  The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. , 2009, European journal of pharmacology.

[79]  M. Jackson,et al.  The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator , 2009, Science.

[80]  L. Obeid,et al.  Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. , 2008, Biochimica et biophysica acta.

[81]  A. Hajipour,et al.  Probing the steroid binding domain-like I (SBDLI) of the sigma-1 receptor binding site using N-substituted photoaffinity labels. , 2008, Biochemistry.

[82]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[83]  Y. Lee,et al.  N,N-Dimethyl-D-erythro-sphingosine inhibits store-operated Ca2+ entry in U937 monocytes. , 2008, Journal of pharmacological sciences.

[84]  Teruo Hayashi,et al.  Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.

[85]  R. Chang,et al.  In vitro and in vivo binding of neuroactive steroids to the sigma‐1 receptor as measured with the positron emission tomography radioligand [18F]FPS , 2007, Synapse.

[86]  A. Ruoho,et al.  Purification and characterization of the guinea pig sigma-1 receptor functionally expressed in Escherichia coli. , 2007, Protein expression and purification.

[87]  A. Hajipour,et al.  Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe. , 2007, Molecular pharmacology.

[88]  L. Obeid,et al.  A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. , 2006, Biochimica et biophysica acta.

[89]  T. Maurice,et al.  The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. , 2006, Journal of pharmacological sciences.

[90]  G. Schultz,et al.  Activation of the Melastatin-Related Cation Channel TRPM3 by d-erythro-Sphingosine , 2005, Molecular Pharmacology.

[91]  Teruo Hayashi,et al.  Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[92]  X. Codony,et al.  Sigma receptors: biology and therapeutic potential , 2004, Psychopharmacology.

[93]  R. Schiffmann,et al.  Glucosylceramide and Glucosylsphingosine Modulate Calcium Mobilization from Brain Microsomes via Different Mechanisms* , 2003, Journal of Biological Chemistry.

[94]  Teruo Hayashi,et al.  Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. , 2003, The Journal of pharmacology and experimental therapeutics.

[95]  P. Casellas,et al.  Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. , 2001, Brain research. Molecular brain research.

[96]  H. Nakayama,et al.  (2R-trans)-2-butyl-5-heptylpyrrolidine as a potent sigma receptor ligand produced by Streptomyces longispororuber. , 2000, The Journal of antibiotics.

[97]  E. Kempner,et al.  Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[98]  A. Bielawska,et al.  (1S,2R)-D-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol as an Inhibitor of Ceramidase (*) , 1996, The Journal of Biological Chemistry.

[99]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[100]  S. Hakomori,et al.  N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. , 1996, Biochemistry.

[101]  W. Bowen,et al.  Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. , 1995, European journal of pharmacology.

[102]  A. Ruoho,et al.  (125I)iodoazidococaine, a photoaffinity label for the haloperidol-sensitive sigma receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[103]  D. W. Parish,et al.  Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand. , 1991, The Journal of pharmacology and experimental therapeutics.

[104]  T. Su,et al.  Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes. , 1991, The Journal of pharmacology and experimental therapeutics.

[105]  Y. Igarashi Possible Roles of Sphingosine and N, N-Dimethylsphingosine as Modulators in Membrane Signal Transduction Systems , 1990 .

[106]  Y. Igarashi,et al.  A specific enhancing effect of N,N-dimethylsphingosine on epidermal growth factor receptor autophosphorylation. Demonstration of its endogenous occurrence (and the virtual absence of unsubstituted sphingosine) in human epidermoid carcinoma A431 cells. , 1990, The Journal of biological chemistry.

[107]  S. Hakomori,et al.  Enzymatic synthesis of N,N-dimethyl-sphingosine: demonstration of the sphingosine: N-methyltransferase in mouse brain. , 1989, Biochemical and biophysical research communications.

[108]  W. Bowen,et al.  Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors. , 1989, FEBS letters.

[109]  E. London,et al.  Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. , 1988, Science.